Literature DB >> 31873311

No statistical evidence for an effect of CCR5-∆32 on lifespan in the UK Biobank cohort.

Robert Maier1,2, Ali Akbari3,4, Xinzhu Wei5, Nick Patterson6,7, Rasmus Nielsen5,8, David Reich9,6,7,10.   

Abstract

Entities:  

Year:  2019        PMID： 31873311      PMCID： PMC7302696          DOI： 10.1038/s41591-019-0710-1

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Retraction Note: CCR5-∆32 is deleterious in the homozygous state in humans.

Authors:  Xinzhu Wei; Rasmus Nielsen
Journal:  Nat Med       Date:  2019-11       Impact factor: 53.440

2.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

3.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

Authors:  Gero Hütter; Daniel Nowak; Maximilian Mossner; Susanne Ganepola; Arne Müssig; Kristina Allers; Thomas Schneider; Jörg Hofmann; Claudia Kücherer; Olga Blau; Igor W Blau; Wolf K Hofmann; Eckhard Thiel
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

4.  HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.

Authors:  Ian H Gabriel; Eduardo Olavarria; Ravindra K Gupta; Sultan Abdul-Jawad; Laura E McCoy; Hoi Ping Mok; Dimitra Peppa; Maria Salgado; Javier Martinez-Picado; Monique Nijhuis; Annemarie M J Wensing; Helen Lee; Paul Grant; Eleni Nastouli; Jonathan Lambert; Matthew Pace; Fanny Salasc; Christopher Monit; Andrew J Innes; Luke Muir; Laura Waters; John Frater; Andrew M L Lever; Simon G Edwards
Journal:  Nature       Date:  2019-03-05       Impact factor: 49.962
  4 in total
  8 in total

1.  Addressing Conflicts of Interest and Conflicts of Commitment in Public Advocacy and Policy Making on CRISPR/Cas-Based Human Genome Editing.

Authors:  Alexander Christian
Journal:  Front Res Metr Anal       Date:  2022-04-27

Review 2.  G protein-coupled receptors that influence lifespan of human and animal models.

Authors:  Francisco Alejandro Lagunas-Rangel
Journal:  Biogerontology       Date:  2021-12-03       Impact factor: 4.277

Review 3.  Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy.

Authors:  Hager Mohamed; Theodore Gurrola; Rachel Berman; Mackenzie Collins; Ilker K Sariyer; Michael R Nonnemacher; Brian Wigdahl
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

4.  Biallelic, Selectable, Knock-in Targeting of CCR5 via CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 Replication.

Authors:  Stefan H Scheller; Yasmine Rashad; Fayez M Saleh; Kurtis A Willingham; Antonia Reilich; Dong Lin; Reza Izadpanah; Eckhard U Alt; Stephen E Braun
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

5.  The CCR5 Gene Edited CD34+CD90+ Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy.

Authors:  Karthik V Karuppusamy; John Paul Demosthenes; Vigneshwaran Venkatesan; Abisha Crystal Christopher; Prathibha Babu; Manojkumar K Azhagiri; Annlin Jacob; Veena Vadhini Ramalingam; Sumathi Rangaraj; Mohankumar Kumarasamypet Murugesan; Srujan Kumar Marepally; George M Varghese; Alok Srivastava; Rajesh Kannangai; Saravanabhavan Thangavel
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

6.  1,000 ancient genomes uncover 10,000 years of natural selection in Europe.

Authors:  Megan K Le; Olivia S Smith; Ali Akbari; Arbel Harpak; David Reich; Vagheesh M Narasimhan
Journal:  bioRxiv       Date:  2022-08-26

Review 7.  Metabolomics as an Approach to Characterise the Contrasting Roles of CCR5 in the Presence and Absence of Disease.

Authors:  Anandi Rautenbach; Aurelia A Williams
Journal:  Int J Mol Sci       Date:  2020-02-21       Impact factor: 5.923

8.  Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission.

Authors:  Xiao L Chang; Gabriela M Webb; Helen L Wu; Justin M Greene; Shaheed Abdulhaqq; Katherine B Bateman; Jason S Reed; Cleiton Pessoa; Whitney C Weber; Nicholas Maier; Glen M Chew; Roxanne M Gilbride; Lina Gao; Rebecca Agnor; Travis Giobbi; Jeffrey Torgerson; Don Siess; Nicole Burnett; Miranda Fischer; Oriene Shiel; Cassandra Moats; Bruce Patterson; Kush Dhody; Scott Kelly; Nader Pourhassan; Diogo M Magnani; Jeremy Smedley; Benjamin N Bimber; Nancy L Haigwood; Scott G Hansen; Timothy R Brown; Lishomwa C Ndhlovu; Jonah B Sacha
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 17.694
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.